In this study, we prospectively monitored CeD-associated antibody production, i.e., AGA, DGP and anti-tTG antibodies, in infants at genetic risk for CeD and correlated the antibody production profiles with systemic cytokine responses. The gene discussed is AGA; the disease is cranioectodermal dysplasia.